Revenue
$52.0M
▼ 18.5% YoY
Net Income
-$265.9M
▼ 37.4% YoY
EPS
$-1.42
▼ 16.4% YoY
Cash
$737.1M
▲ 88.0% YoY
FY 2025 · As of 2025-12-31
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
Dugel Pravin See Remarks | Gift | Apr 9, 2026 | 394.7K | $0.00 | $0 | Form 4 ↗ |
Dugel Pravin See Remarks | Gift | Apr 9, 2026 | 394.7K | $0.00 | $0 | Form 4 ↗ |
Dugel Pravin See Remarks | Sell | Feb 23, 2026 | 20.1K | $8.28 | $166K | Form 4 ↗ |
Kaiser Peter Chief Development Officer | Sell | Feb 23, 2026 | 2.8K | $8.28 | $23K | Form 4 ↗ |
Heier Jeffrey S. Chief Scientific Officer | Sell | Feb 23, 2026 | 3.1K | $8.28 | $25K | Form 4 ↗ |
Nayak Sanjay Chief Strategy Officer | Sell | Feb 23, 2026 | 1.8K | $8.28 | $15K | Form 4 ↗ |
Waheed Nadia Chief Medical Officer | Sell | Feb 20, 2026 | 3.5K | $7.74 | $27K | Form 4 ↗ |
LINDSTROM RICHARD L MD | Buy | Feb 20, 2026 | 60.2K | $7.66 | $461K | Form 4 ↗ |
Notman Donald Chief Operating Officer | Sell | Feb 12, 2026 | 11.4K | $9.04 | $103K | Form 4 ↗ |
Nayak Sanjay Chief Strategy Officer | Sell | Feb 12, 2026 | 10.3K | $9.04 | $94K | Form 4 ↗ |
Dugel Pravin See Remarks | Sell | Feb 12, 2026 | 124.9K | $9.04 | $1.13M | Form 4 ↗ |
Waheed Nadia Chief Medical Officer | Sell | Feb 12, 2026 | 7.9K | $9.04 | $71K | Form 4 ↗ |
Notman Donald Chief Operating Officer | Sell | Feb 4, 2026 | 6.0K | $8.54 | $52K | Form 4 ↗ |
Notman Donald Chief Operating Officer | Sell | Feb 2, 2026 | 5.5K | $9.14 | $50K | Form 4 ↗ |